Knee Osteoarthritis stem cell therapy — your questions answered (2026)

About stem cell therapy for Knee Osteoarthritis

Knee osteoarthritis is a whole-joint disorder involving cartilage, bone, synovium, muscle and mechanics. Autologous marrow or adipose preparations, culture-expanded MSCs, stromal vascular fraction and exosomes are distinct products. An anti-inflammatory signal or injection into the joint does not establish cartilage regrowth or prevention of joint replacement.

The evidence for Knee Osteoarthritis

Studies should be assessed by exact product and processing, imaging guidance, comparator, baseline severity, pain and function outcomes, structural endpoints, rescue medication, adverse events and duration. The FDA consumer alert states that the promoted regenerative products it addresses have not been approved in the United States for orthopaedic conditions including knee pain and osteoarthritis. The NIAMS osteoarthritis guide describes established non-operative and surgical options.

Itemise assessment, exact injectate, imaging guidance, number of injections, rehabilitation, medicines, travel, follow-up and complication care. Compare with exercise, weight management where relevant, authorised symptom treatment and surgical assessment; do not treat a higher cell count or price as proof of benefit.

Can stem cells regrow knee cartilage?

Cell therapy for Knee Osteoarthritis may be offered as an individualised programme, but regulatory status depends on the product, processing, indication and jurisdiction. It is currently investigational. Verify authorisation status, cell source, release testing and clinical evidence for the specific proposal.

Will it delay a knee replacement?

Schedules vary by the exact product, protocol, route, monitoring needs and clinical context. Request the proposed schedule and its evidence before making travel arrangements.

One injection or several?

Eligibility depends on the protocol's inclusion and exclusion criteria and an appropriately qualified clinician's assessment. An online checklist cannot determine candidacy or replace medical advice.

EU cost for knees?

The partner-published indicative range for an Knee Osteoarthritis programme is €3,000–€8,000 for treatment. Request a current written quotation and compare product, dose, visits, inclusions and follow-up before using country ranges as a benchmark.

Sources & further reading

We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.

• Open clinical trials for Knee Osteoarthritis (ClinicalTrials.gov) ↗
• Peer-reviewed research on PubMed ↗
• ISSCR patient guide — what to ask ↗
• FDA consumer warning on stem-cell therapies ↗
• EMA — advanced-therapy (ATMP) framework ↗
• Clinic perspective — Stem Plus on Knee Osteoarthritis ↗

← Back to Knee Osteoarthritis overview · Knee Osteoarthritis cost →